Sharma, V., Bagrodia, V. and Kulshreshtra, A. 2024. Enhancing hemophilia A management: emicizumab as a cost-effective adjunct to standard therapy for inhibitor patients. International Journal of Basic & Clinical Pharmacology. 13, 3 (Apr. 2024), 395–397. DOI:https://doi.org/10.18203/2319-2003.ijbcp20241000.